1. Voloudakis, Georgios, Vicari, James M, Venkatesh, Sanan, Fullard, John F, Roussos, Panos. 2022. A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility. In NPJ genomic medicine, 7, 52. doi:10.1038/s41525-022-00324-x. https://pubmed.ncbi.nlm.nih.gov/36064543/
2. Motallebi, Farzaneh, Al Sudani, Zainab M, Vaghefi, Fatemeh, Kowsari, Ali, Oladnabi, Morteza. 2024. A novel biallelic 19-bp deletion in the IL10RB gene caused infant-onset inflammatory bowel disease in a consanguineous family: a molecular docking simulation study and literature review. In Molecular biology reports, 51, 223. doi:10.1007/s11033-024-09248-4. https://pubmed.ncbi.nlm.nih.gov/38281300/
3. Voloudakis, Georgios, Hoffman, Gabriel, Venkatesh, Sanan, Fullard, John F, Roussos, Panos. 2021. IL10RB as a key regulator of COVID-19 host susceptibility and severity. In medRxiv : the preprint server for health sciences, , . doi:10.1101/2021.05.31.21254851. https://pubmed.ncbi.nlm.nih.gov/34100031/
4. Grk, Milka, Miskovic, Rada, Jeremic, Ivica, Cirkovic, Andja, Banko, Ana. 2023. Association of IL10RA, IL10RB, and IL22RA Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE. In International journal of molecular sciences, 24, . doi:10.3390/ijms241411292. https://pubmed.ncbi.nlm.nih.gov/37511050/
5. Romporn, S, Hirankarn, N, Tangkijvanich, P, Kimkong, I. . Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection. In Tissue antigens, 82, 21-5. doi:10.1111/tan.12133. https://pubmed.ncbi.nlm.nih.gov/23745570/
智鼠故事 
